Compare Repligen Corporation Common Stock (RGEN) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Valero Energy Corporation — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B), while Valero Energy Corporation trades at $461.44 (market cap $131.43B). The key difference: Valero Energy Corporation is far larger — about 11.6× Repligen Corporation Common Stock's market cap, and Valero Energy Corporation pays a 1.05% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Valero Energy Corporation for 57 Days on average.
| RGEN | VLO | |
|---|---|---|
Market Cap | $11.31B | $131.43B |
Volume | 1,216,919 | 2,513,030 |
Sector | Health | Energy |
52-Week High | $194.57 | $459.78 |
52-Week Low | $102.87 | $156.39 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $11.20B | $134.90B |
Dividend Yield | — | 1.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Valero Energy (VLO) trades at $456.46, up 4.69% today and near its 52-week high, with a bullish technical outlook supported by moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 expected at $20.83 EPS. Revenue declined to $122.69B in 2025, but net income margin improved to 5.17%, and strong cash flow supports a $1.20 dividend. Analyst sentiment is positive with 57% buy ratings.
VLO presents a bullish case with robust profitability and growth prospects, but faces risks from volatile refining margins and potential policy impacts like diesel export bans. The stock's valuation at a P/E of 19.04 is reasonable given high ROE of 29.31%, though high RSI levels suggest caution for near-term entry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
